Nestlé has initiated a voluntary recall of limited batches of infant formula in Uzbekistan due to a potential contamination risk involving one of the product’s ingredients supplied by an external vendor. The decision, described as precautionary, was announced by Nestlé Food LLC, the company’s local subsidiary.
The recall affects select batches of dry instant milk and fermented milk-based formulas, as well as certain amino acid-based products intended for infants on specialized medical diets. The affected items include NAN 1 OPTIPRO, NAN 2 OPTIPRO, NAN Kislomolochniy (for infants up to 12 months), NAN Supreme (same age group), and ALFARÉ Amino. Nestlé Food LLC clarified that the recall applies only to the specified batches and does not impact other infant nutrition products sold in Uzbekistan.
The company said the action follows a global recall initiated after a potential contamination with cereulide toxin was identified in arachidonic acid sourced from an external supplier. Although the quantity of this ingredient is minimal and Uzbekistan does not impose regulatory limits for cereulide in food products, Nestlé opted for a voluntary recall to mitigate any possible risk. The recall process began in Uzbekistan on January 5, 2026.
Nestlé Food LLC confirmed it has informed local regulators and is prepared to provide comprehensive information to authorities, consumers, and retail partners. Consumers who purchased products from the affected batches can return them according to company-issued procedures. Customer support services are available to assist with the process.
Similar precautionary measures have been announced in Kazakhstan. There, Nestlé is also recalling a limited number of infant food products, including dry and sour-milk formulas, as well as amino acid-based dietary items. The company explained that cereulide is a toxin produced by the bacterium Bacillus cereus. It is particularly hazardous because it cannot be destroyed by boiling or reheating. Exposure to cereulide can cause acute food poisoning, with symptoms including nausea, vomiting, and abdominal pain.
The issue is not confined to Central Asia. Reuters reported that Nestlé has also recalled certain batches of its SMA, BEBA, and NAN infant formulas across parts of Europe due to the same contamination risk.
Nestlé emphasized that consumer health and safety remain its highest priority. The company stated that the recall is a precautionary step aligned with its global quality and safety standards, and that no confirmed cases of harm have been reported to date.
